Immune Consequences of Decreasing Tumor Vasculature with Antiangiogenic Tyrosine Kinase Inhibitors in Combination with Therapeutic Vaccines
Benedetto Farsaci, James W. Hodge(Center for Cancer Research)
Cited by 80
Related Papers
Radiation-induced immunogenic modulation of tumor enhances antigen processing and calreticulin exposure, resulting in enhanced T-cell killing
|Oncotarget|2013|397
Dual effects of a targeted small-molecule inhibitor (cabozantinib) on immune-mediated killing of tumor cells and immune tumor microenvironment permissiveness when combined with a cancer vaccine
|Journal of Translational Medicine|2014|189
PD-L1 targeting high-affinity NK (t-haNK) cells induce direct antitumor effects and target suppressive MDSC populations
|Journal for ImmunoTherapy of Cancer|2020|148
Inhibitors of histone deacetylase 1 reverse the immune evasion phenotype to enhance T-cell mediated lysis of prostate and breast carcinoma cells
|Oncotarget|2016|104
Expanding the use of monoclonal antibody therapy of cancer by using ionising radiation to upregulate antibody targets
|British Journal of Cancer|2014|27